Literature DB >> 20605399

Strategies for radiation-dose reduction and image-quality optimization in multidetector computed tomographic coronary angiography.

Felipe S Torres1, Andrew M Crean, Elsie T Nguyen, Narinder Paul.   

Abstract

The technological evolution of computed tomography (CT) in the last decade has placed CT coronary angiography (CTCA) in the spotlight of imaging modalities available to evaluate patients with coronary artery disease. Widespread utilisation of CTCA has generated concern from the medical community regarding potential health issues related to the significant radiation exposure associated with this method, and several modifications of the CTCA technique have been proposed to reduce the radiation exposure without affecting the diagnostic image quality. This review will discuss a practical approach to performing CTCA to ensure that the radiation dose is minimized while maintaining diagnostic image quality.
Copyright © 2010 Canadian Association of Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605399     DOI: 10.1016/j.carj.2009.11.013

Source DB:  PubMed          Journal:  Can Assoc Radiol J        ISSN: 0846-5371            Impact factor:   2.248


  2 in total

1.  Failed heart rate control with oral metoprolol prior to coronary CT angiography: effect of additional intravenous metoprolol on heart rate, image quality and radiation dose.

Authors:  Laura Jiménez-Juan; Elsie T Nguyen; Bernd J Wintersperger; Hadas Moshonov; Andrew M Crean; Djeven P Deva; Narinder S Paul; Felipe S Torres
Journal:  Int J Cardiovasc Imaging       Date:  2012-04-24       Impact factor: 2.357

2.  Reduced exposure using asymmetric cone beam processing for wide area detector cardiac CT.

Authors:  Arash Bedayat; Frank J Rybicki; Kanako Kumamaru; Sara L Powers; Jason Signorelli; Michael L Steigner; Chloe Steveson; Shigeyoshi Soga; Kimberly Adams; Dimitrios Mitsouras; Melvin Clouse; Richard T Mather
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-19       Impact factor: 2.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.